Identifying amount of required healthcare The G-BA developed the needs planning directive (German: Bedarfsplanungs-Richtlinie) to give national rules on “how much” SHI-funded
Read More
The process of determining the reimbursed price of a product with a new chemical entity is clearly defined and follows specific steps.
Read More
Wound treatment materials and products are considered medical devices. The GVWG (§31 (1a) SGB V) from 2 December 2020 introduced a new
Read More
The G-BA has 13 voting members forming the so-called plenum. The representatives of care providers are only entitled to vote on topics
Read More
Drugs that primarily aim to increase the quality of life are so-called “lifestyle” drugs. These are not covered by the SHI funds
Read More
Posts navigation